References
- Akbarzadehbaghban A, Esmaeili M, Kimiafar K (2009). Medical information management and assessment of direct costs of treatment of lung cancer. Health Information Manage, 5, 15-21.
- Bazyar M, Pourreza A, Harirchi I, et al (2012). Medical and non-medical direct costs of cancers in patients hospitalized in Imam Khomeini cancer institution-2010. Hospital, 11, 39-50.
- Bradley CJ, YabroffKR, DahmanB, et al (2008). Productivity costs of cancer mortality in the United States: 2000?2020. J Natl Cancer Inst, 100, 1763-70. https://doi.org/10.1093/jnci/djn384
- Daroudi RA, Akbari SariA, Nahvijou A, et al (2015). The economic burden of breast cancer in Iran. Iran J Public Health, 44, 1225.
- Doran CM , Ling R, Byrnes J, et al (2015). Estimating the economic costs of skin cancer in New South Wales, Australia. BMC public health , 1, 952.
- Forouzanfar MH, Sepanlou SG, Shahraz S, et al (2014). Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med, 17, 304-320.
- Hanly PA, Sharp L (2014). The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer, 14, 224 https://doi.org/10.1186/1471-2407-14-224
- Insinga RP (2006). Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues, 16, 236-42. https://doi.org/10.1016/j.whi.2006.06.005
- Jemal A, F. Bray, MM. Center, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Jonsson B, Wilking N (2007). The burden and cost of cancer. Ann Oncol, 18, 8-22.
- Abachizadeh K, Mohagheghi MA, Mosavi-Jarrahi A (2011). Setting research priorities to reduce burden of cancer in Iran: an institutional experience. Asian Pac J Cancer Prev, 12, 2365-70.
- Khorasani S, Rezaei S, Rashidian H, et al (2014). Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran. Asian Pac JCancer Prev, 16, 1845-50.
- Kim JL, Cho KH, Park EC, et al (2013). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9.
- Menzin J, Marton JP, Menzin JA, et al (2012). Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation. BMC Med Res Methodol, 12, 87. https://doi.org/10.1186/1471-2288-12-87
- Naghavi M, Abolhassani F, PourmalekF, et al (2009). The burden of disease and injury in Iran 2003. Popul Health Metr, 7, 9-15. https://doi.org/10.1186/1478-7954-7-9
- Ortiz-Ortiz KJ, Perez-Irizarry J, Marin-CentenoH, et al (2010). Productivity loss in Puerto Rico’s labor market due to cancer mortality. P R Health Sci J, 29, 241-9.
- LozanoR, NaghaviM, Foreman K, et al (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-2128.
- Rashidian H, Davoudi R, Ghiasvand R (2013). Prevalence and Incidence of premenopausal and postmenopausal breast cancer in Iran in 2010. Basic Clinical Cancer Res, 5, 2-10.
- Rezaei S, Akbari SariA, ArabM, et al (2015). Estimating economic burden of cancer deaths attributable to smoking in Iran in 2012. J Res Health Sci, 15, 228-33.
- Song X, Quek RG, Gandra SR, et al (2015). Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures. BMC Health Serv Res, 1, 254.
- Taghavi A, Fazeli Z, Vahedi M (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
- Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108. https://doi.org/10.3322/caac.21262
Cited by
- Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention vol.63, pp.7, 2018, https://doi.org/10.1038/s10038-018-0450-y